Inactive Instrument

AroCell AB (publ) Stock price Nasdaq Stockholm

Equities

SE0003883990

Biotechnology & Medical Research

Sales 2023 * 45.1M 4.24M Sales 2024 * 61M 5.73M Capitalization 85M 7.98M
Net income 2023 * -57M -5.35M Net income 2024 * -51M -4.79M EV / Sales 2023 * 0.82 x
Net cash position 2023 * 48M 4.51M Net cash position 2024 * 36M 3.38M EV / Sales 2024 * 0.8 x
P/E ratio 2023 *
-0.18 x
P/E ratio 2024 *
-1.85 x
Employees -
Yield 2023 *
-
Yield 2024 *
-
Free-Float 56.52%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 50 18-11-30
Director of Finance/CFO 67 -
Chief Operating Officer - -
Members of the board TitleAgeSince
Chairman 65 21-12-31
Director/Board Member 63 21-04-30
Director/Board Member 72 22-12-31
More insiders
AroCell publ AB is a Sweden-based diagnostic Company engaged in the development of markers for determination of cell growth (TK 210) and apoptosis. The Company's principal product candidate, TK-immuno/hem, is a test for monitoring and follow up of blood cancer. The test is based on a patented technology, which have already been evaluated in an early product prototype ELISA method. Apart from that, the Company develops a marker for solid tumor cancer disease. The AroCell cooperates with partners within development, production and sales.
Calendar
More about the company
  1. Stock
  2. Equities
  3. Stock AroCell AB
  4. Stock AroCell AB (publ) - Nasdaq Stockholm